Modular Medical, Inc.: Form 10-Q for the period ended Dec 31, 2025
Filed with the SEC on Feb 17, 2026 and accepted by EDGAR at Feb 17, 2026, 16:00 ET.
Sections
The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2025-12-31. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Research and development | 3 months2025-10-01 to 2025-12-31 | $5.4m | us-gaap:ResearchAndDevelopmentExpense |
| Research and development | 9 months2025-04-01 to 2025-12-31 | $16.1m | us-gaap:ResearchAndDevelopmentExpense |
| Operating income | 3 months2025-10-01 to 2025-12-31 | −$7.2m | us-gaap:OperatingIncomeLoss |
| Operating income | 9 months2025-04-01 to 2025-12-31 | −$21.9m | us-gaap:OperatingIncomeLoss |
| Income tax | 9 months2025-04-01 to 2025-12-31 | $2.0k | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months2025-10-01 to 2025-12-31 | −$7.4m | us-gaap:NetIncomeLoss |
| Net income | 9 months2025-04-01 to 2025-12-31 | −$21.9m | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months2025-10-01 to 2025-12-31 | −$0.11 | us-gaap:EarningsPerShareDiluted |
| Diluted EPS | 9 months2025-04-01 to 2025-12-31 | −$0.37 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months2025-10-01 to 2025-12-31 | −$0.11 | us-gaap:EarningsPerShareBasic |
| Basic EPS | 9 months2025-04-01 to 2025-12-31 | −$0.37 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 3 months2025-10-01 to 2025-12-31 | 65,930,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Diluted shares (weighted) | 9 months2025-04-01 to 2025-12-31 | 58,614,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 9 months2025-04-01 to 2025-12-31 | −$17.9m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 9 months2025-04-01 to 2025-12-31 | $2.9m | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Cash and equivalents | At period end2025-12-31 | $2.9m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | At period end2025-12-31 | $3.5m | us-gaap:AssetsCurrent |
| Total assets | At period end2025-12-31 | $10.3m | us-gaap:Assets |
| Current liabilities | At period end2025-12-31 | $2.2m | us-gaap:LiabilitiesCurrent |
| Total liabilities | At period end2025-12-31 | $4.4m | us-gaap:Liabilities |
| Shareholders' equity | At period end2025-12-31 | $5.9m | us-gaap:StockholdersEquity |
Source: SEC EDGAR, the filing index for accession 0001213900-26-017262. Last ingested by Listed: Oct 29, 2026, 16:11 ET. Listed shows no prices and gives no investment advice.